Risk perception in healthy women with a family history of breast cancer: results of a prospective observational study

2021 ◽  
Author(s):  
A Tüchler ◽  
J Dick ◽  
A Brédart ◽  
D Stoppa-Lyonnet ◽  
RK Schmutzler ◽  
...  
Psico ◽  
2018 ◽  
Vol 49 (3) ◽  
pp. 266
Author(s):  
Carolina Ribeiro Seabra ◽  
Maria Júlia Armiliato ◽  
Luisa Vital ◽  
Paola Otaran ◽  
Ana Carolina Peuker ◽  
...  

Background: Early detection of breast cancer (BC) is important to reduce mortality rates. To prevent BC, women should adopt self-care behaviors. This study aimed at examining risk and illness perception and self-care of healthy women regarding breast cancer. Methods: Participants were 211 women (M = 59.11 years, SD = 8.54) and with no personal history of the illness, selected by convenience. Measures were a sociodemographic, clinical and health behavior questionnaire, illness perception and risk perception questionnaires. Nonparametric statistics (Spearman) was employed to analyze the relationship between illness perception, risk perception and sociodemographic variables. The open answers to the causes of the illness were classified according to the content analysis. Results: We found a relationship between risk and illness perception and self-care in healthy women regarding BC. It was identified that women had reasonable illness coherence (M = 3.18) and considered the illness more timeline chronic than timeline acute (M = 3.22), reasonable timeline cyclical (M = 3.56), with severe consequences for health (M = 4.22), and reasonably threatening (M = 3.15). Conclusions: BC and risk perception and self-care are interrelated variables among healthy women. ***Prevenção do cancer de mama: o que as mulheres pensam sobre a doença, seus riscos e autocuidado***Introdução: A detecção precoce do câncer de mama (CM) é importante para reduzir as taxas de mortalidade. Para preveni-lo, a mulher deve adotar comportamentos de autocuidado em saúde. Esse estudo objetiva examinar a percepção de risco, a percepção da doença e o autocuidado de mulheres saudáveis com relação ao CM. Método: Participaram 211 mulheres (M = 59,11 anos; DP = 8,54) sem histórico de CM selecionados por conveniência. Os instrumentos foram questionário de dados sociodemográficos, clínicos e decomportamento em saúde, questionários de percepção da doença e percepção de risco. Estatística não paramétrica (Spearman) foi utilizada para analisar a relação entre percepção da doença, percepção de risco e variáveis sociodemográficas. As respostas abertas sobre as causas da doença foram classificadas segundo análise de conteúdo. Resultados: Observou-se que existe relação entre a percepção de risco e da doença, e autocuidado em mulheres saudáveis. Identificou-se que as mulheres têm razoável percepção de entendimento da doença (M = 3.18), a consideravam mais crônica que aguda (M = 3.22), razoavelmente cíclica (M = 3,56), com consequências graves à saúde (M = 4,22), e relativamente ameaçadora (M = 3,15). Conclusões: A percepção do CM, a percepção de risco e o autocuidado são variáveis inter-relacionadas em mulheres saudáveis.Palavras-chave: Neoplasias; Autorregulação; Câncer de mama; Autocuidado.


2020 ◽  
Vol 9 (10) ◽  
pp. 3063
Author(s):  
Juan de Dios Berná-Serna ◽  
Florentina Guzmán-Aroca ◽  
José A. García-Vidal ◽  
Dolores Hernández-Gómez ◽  
Ana Azahara García-Ortega ◽  
...  

The aim of this study was to investigate the usefulness of platelet-rich plasma (PRP) treatment for chronic wounds (CWs) of the breast. A prospective study was performed in 23 patients with CW of the breast who were treated with PRP. The procedure was repeated until the wound was closed completely. The study included patients with a history of breast cancer (n = 8) and patients without cancer (n = 15). The treatment with PRP was successful in all cases and observed in ≤4 weeks in 82.6% (19/23) of patients. The patients without breast cancer showed significantly less time for wound closure than the patients with a history of breast cancer. Moreover, a greater number of PRP treatments were necessary to achieve wound closure in patients undergoing conservative breast treatment. No patients had complications associated with the application of PRP. Conclusions: To the best of our knowledge, this is the first study to reveal that PRP treatment for CWs of the breast is safe, simple, useful and well-tolerated by patients.


2009 ◽  
Vol 32 (4) ◽  
pp. 299-308 ◽  
Author(s):  
Denise Spector ◽  
Merle Mishel ◽  
Celette Sugg Skinner ◽  
Lisa A. DeRoo ◽  
Marcia VanRiper ◽  
...  

2001 ◽  
Vol 24 (5) ◽  
pp. 470-475 ◽  
Author(s):  
C. Neise ◽  
M. Rauchfuss ◽  
S. Paepke ◽  
K. Beier ◽  
W. Lichtenegger

1999 ◽  
Vol 79 (5-6) ◽  
pp. 868-874 ◽  
Author(s):  
M Watson ◽  
S Lloyd ◽  
J Davidson ◽  
L Meyer ◽  
R Eeles ◽  
...  

Author(s):  
Trevor J Powles ◽  
Anthony Howell ◽  
D Gareth Evans ◽  
Eugene V Mccloskey ◽  
Sue Ashley ◽  
...  

Objective To assess the safety and tolerability of a standardized 40 mg red clover isoflavone dietary supplement (Promensil®, Novogen) in women with a family history of breast cancer to evaluate the feasibility of using the supplement for prevention of breast cancer in healthy women. Study design Healthy women aged 35–70 years (n = 401) with at least one first-degree relative with breast cancer received red clover isoflavones or placebo for three years in a randomized, double-blind, placebo-controlled pilot trial. Participants were assessed clinically and blood samples taken for biochemical analysis every six months. In addition, study participants underwent mammography, bone density and transvaginal ultrasound (postmenopausal women only) once per year. Results No significant differences in breast density, endometrial thickness, serum cholesterol, follicle stimulating hormone levels and bone mineral density were detected between those taking red clover isoflavones and placebo. In postmenopausal women, some significant differences in bone marker levels were seen between active and placebo groups, at six months and at 12 months. The adverse event profile was similar across all red clover isoflavone and placebo groups. Conclusion This three-year study supports the growing body of evidence that treatment with red clover isoflavones is safe and well tolerated in healthy women. Supplements containing red clover isoflavones did not adversely affect breast density, skeletal strength or cardiovascular status. In postmenopausal women, endometrial status was not adversely affected. The adverse event profile was similar between red clover isoflavones, and placebo and endocrine status did not differ.


1994 ◽  
Vol 70 (5) ◽  
pp. 934-938 ◽  
Author(s):  
DGR Evans ◽  
V Blair ◽  
R Greenhalgh ◽  
P Hopwood ◽  
A Howell

Sign in / Sign up

Export Citation Format

Share Document